VetStem Biopharma Open Veterinary GMP Cell Manufacturing Center In Poway, California
02/24/2017
According to company officials, this clean room facility has already produced three registration batches of stem cell product and those batches have been officially released for use in pivotal FDA studies of safety and efficacy. The facility operates under FDA GMP guidelines and is designed to produce commercial products, once approved by the FDA.
Carolyn Wrightson, Ph.D., Vice President, Operations, stated, “This facility is the culmination of six years of planning and research, supported by over 12 years of commercial stem cell laboratory operations by VetStem’s experienced cell therapy team. We believe this is the first dedicated veterinary-specific cell therapy facility in the United States. It will provide all the stem cell products for use in VetStem FDA product development programs.”
“Quality is a critical element necessary to bring stem cell therapy into mainstream veterinary practice. VetStem has been committed to quality since its founding and has worked directly with the FDA Center for Veterinary Medicine since 2003 to assure our products and services adhere to the strictest guidelines for safety and efficacy,” said Bob Harman, DVM, MPVM, CEO of VetStem. “VetStem offers tours of this unique facility via large viewing windows in an exterior corridor and veterinarians are amazed at the high tech approach to veterinary cell therapy including the specialized approach to donor selection, disease screening, clean room cell culture and final packaging of the product in specialized cell product vials.”
“Stem cell therapy is a truly novel and natural approach to treatment of acute and chronic diseases in animals that have few or less efficacious therapeutic options. Using donor derived allogeneic stem cells provides cell therapy in a “ready to use” format without the need for tissue collection, or processing thus expanding the availability to more animals. VetStem is dedicated to providing affordable stem cell therapy for diseases of dogs, cats and horses, especially in areas of unmet needs,” according to Harman.
Project Announcements
Delta Star Expands Lynchburg, Virginia, Manufacturing Operations
04/21/2025
Gillespie Precast Plans Asheboro, North Carolina, Manufacturing Operations
04/21/2025
Japan-Based TMEIC Corporation Americas Plans Waller County, Texas, Manufacturing Operations
04/21/2025
South Korea-Based Samkwang Plans Tuskegee, Alabama, Operations
04/21/2025
CRH Plans Roswell, Georgia, Operations
04/21/2025
GE Aerospace Expands Batesville, Mississippi, Manufacturing Operations
04/20/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
The Location Economics of Advanced Nuclear
Q1 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Designing Beyond the Assembly Line
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025